- Conditions
- Benign Skin Growth, Non-Melanoma Skin Cancer (NMSC)
- Locations
-
- Dartmouth Hitchcock Lebanon, New Hampshire, United States
Clinical trial condition
Non-Melanoma Skin Cancer (NMSC)
Explore clinical trials studying Non-Melanoma Skin Cancer (NMSC). Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Non-Melanoma Skin Cancer (NMSC) trial results
NCT04844528
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Enrolling by Invitation
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
NCT07347392
- Conditions
- Basal Cell Carcinoma of Skin, Carcinoma, Carcinoma, Basal Cell, +6 more
- Locations
-
- Aarhus University Hospital Aarhus N, Denmark
Not Yet Recruiting
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom
NCT07361666
- Conditions
- Basal Cell Carcinoma (BCC), Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of the Head and Neck, +22 more
- Locations
-
- National Medical Institute of the Ministry of the Interior and Administration in Warsaw Warsaw, Masovian Voivodeship, Poland
NCT01662713
- Conditions
- Neoplasms, Neoplasms by Site, Non-Melanoma Skin Cancer (NMSC), +3 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02941900
- Conditions
- Non-Melanoma Skin Cancer (NMSC)
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- University of Birmingham Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- Carti Cancer Center Little Rock, Arkansas, United States